CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for HALEON PLC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

HALEON PLC
Building 5, First Floor, The Heights
Phone: +44 1932822000p:+44 1932822000 WEYBRIDGE, KT13 0NY  United Kingdom Ticker: HLNHLN
Business Summary
Haleon plc is a consumer healthcare company. The Company's product portfolio includes five categories, including oral health, vitamins, minerals, and supplements (VMS), pain relief, respiratory health, digestive health and others. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA and LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company's digestive health and other product offerings also include skin health and smoker’s health. Its oral health brands include Sensodyne, Polident, Parodontax, and Biotene. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, and Flonase. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Fenistil.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-YesYes--

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations
2844 Perfumes, cosmetics, and other toilet preparations
5122 Drugs, drug proprietaries, and druggists' sundries
8731 Commercial physical and biological research
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Non-Executive Chairman of the Board DaveLewis 58 5/23/2022 5/23/2022
Chief Executive Officer, Executive Director BrianMcnamara 57 5/23/2022 5/23/2022
Chief Financial Officer, Executive Director Dawn A.Allen 55 11/1/2024 11/1/2024
12 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Haleon Netherlands Capital BV The Heights Building 5 Surrey United Kingdom
Haleon UK Capital plc BUILDING 5, FIRST FLOOR THE HEIGHTS WEYBRIDGE United Kingdom
GSK Consumer Healthcare Capital US LLC 184 LIBERTY CORNER ROAD WARREN New Jersey United States
Haleon Canada ULC 55 Standish Ct Mississauga ON Canada

Business Names
Business Name
HALEON CANADA ULC
Haleon Netherlands Capital BV
HLN
HLN WI

General Information
Number of Employees: 24,000 (As of 12/31/2023)
Outstanding Shares: 9,053,360,882 (As of 10/3/2024)
Shareholders: 61,447
Stock Exchange: LON


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024